.FDA grants approval for APP Pharmaceuticals drug APP Pharmaceuticals receives FDA approval to market generic infection treatment
Buzz up! 0 Print..Companies:Fresenius Kabi PharmaceuticalsBristol-Myers Squibb Company.On Monday June 21, 2010, 8:36 am SCHAUMBURG, Ill. (AP) -- APP Pharmaceuticals received marketing approval for its generic anti-infective treatment, the company said Monday.
The Food and Drug Administration gave approval to market Aztreonam for Injection in two dosage strengths, 1 gram 20 milliliters and 2 grams 30 milliliters. APP plans to launch Aztreonam immediately.
It said Aztreonam is therapeutically equivalent to the Bristol-Myers Squibb Co. drug Azactam. The branded product had about $86 million in U.S. sales last year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.